Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomas

Mol Cancer. 2022 Jan 7;21(1):13. doi: 10.1186/s12943-021-01484-7.

Abstract

Circular RNAs (circRNAs) are classified as noncoding RNAs because they are devoid of a 5' end cap and a 3' end poly (A) tail necessary for cap-dependent translation. However, increasing numbers of translated circRNAs identified through high-throughput RNA sequencing overlapping with polysome profiling indicate that this rule is being broken. CircRNAs can be translated in cap-independent mechanism, including IRES (internal ribosome entry site)-initiated pattern, MIRES (m6A internal ribosome entry site) -initiated patterns, and rolling translation mechanism (RCA). CircRNA-encoded proteins harbour diverse functions similar to or different from host proteins. In addition, they are linked to the modulation of human disease including carcinomas and noncarcinomas. CircRNA-related translatomics and proteomics have attracted increasing attention. This review discusses the progress and exclusive characteristics of circRNA translation and highlights the latest mechanisms and regulation of circRNA translatomics. Furthermore, we summarize the extensive functions and mechanisms of circRNA-derived proteins in human diseases, which contribute to a better understanding of intricate noncanonical circRNA translatomics and proteomics and their therapeutic potential in human diseases.

Keywords: Cap-independent; Carcinomas; Circular RNA; Protein; Translation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers
  • Carcinoma / genetics
  • Drug Resistance, Neoplasm
  • Gene Expression Regulation*
  • Humans
  • Internal Ribosome Entry Sites
  • Open Reading Frames
  • Promoter Regions, Genetic
  • Protein Biosynthesis*
  • RNA Splicing
  • RNA, Circular / genetics*
  • RNA, Messenger / genetics*

Substances

  • Biomarkers
  • Internal Ribosome Entry Sites
  • RNA, Circular
  • RNA, Messenger